Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Market Perform on Oak Street Health, Raises Price Target to $39

SVB Leerink analyst Whit Mayo maintains Oak Street Health (NYSE:OSH) with a Market Perform and raises the price target from $33 to $39.
byBenzinga Newsdesk
February 8, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Whit Mayo maintains Oak Street Health (NYSE:OSH) with a Market Perform and raises the price target from $33 to $39.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Aditxt Stock Is Volatile Today

By Erica Kollmann
April 2, 12:42 PM
Aditxt's wholly owned subsidiary, Adivir, Inc. will acquire all issued and outstanding Class A common shares of Appili in the transaction. Appili has developed FDA-approved Likmez (previously ATI-1501), its ATI-1701 biodefense program supported by a USD $14 million non-dilutive award from the U.S Department of Defense, and its ATI-1801 topical formulation targeting cutaneous leishmaniasis.

ADTX